The Journal of Organic Chemistry
Article
respectively. These host concentrations were chosen to ensure
complete host−guest complexation at the highest concentration. Six
NMR samples of varying host/guest ratios were prepared for each
host/guest pair, and the N−H resonance of 6 was monitored over the
temperature range 298−328 K. All temperatures were calibrated using
a MeOH temperature standard.48
Computational Details. Calculations were performed using the
Gaussian 0949 software package with the GaussView50 graphical user
interface. Graphical representations were produced using the UCSF
Chimera package v1.8.51 Initial conformational searches and
optimizations were performed using either the 3-21g or 6-31g basis
set, followed by full geometry optimizations and unscaled frequency
calculations at the B3LYP/6-31+G(d,p) level of theory using the IEF-
PCM solvation model for chloroform. Frequency calculations were
performed on all converged structures confirming that they
corresponded to local minima. Calculated enthalpies are reported as
zero-point corrected enthalpies. In all cases, the lowest energy
conformer was used to compare the relative energetics of the
calculated species.
removed and the reaction was allowed to warm to room temperature
overnight while stirring under N2. The reaction was concentrated by
rotary evaporation, and the crude product was purified by column
chromatography (SiO2, EtOAc) to afford a white crystalline solid (3.88
g, 66%). Mp = 128−129 °C. 1H NMR (500 MHz, CDCl3) δ: 7.97 (d,
J = 7.8 Hz, 1H), 7.91 (d, J = 7.5 Hz, 1H), 7.74 (m, 1H), 7.71 (s, 1H),
2.23 (s, 3H), 1.35 (s, 9H). 13C{1H} NMR (125 MHz, CDCl3) δ:
176.9, 168.4, 149.7, 149.3, 140.9, 109.5, 109.3, 39.8, 27.5, 24.8. HRMS
(ESI-TOF) m/z: [M + H]+ Calcd for C12H18N3O2, 236.1399; found
236.1402.
N-(6-Acetamidopyridin-2-yl)benzamide (1e). The disubstituted
diaminopyridine 1e was prepared according to the general procedure
outlined for 1d with the following quantities: benzoyl chloride (1.9
mL, 16 mmol) in THF (25 mL) was added slowly to 2a (1.9 g, 13
mmol) and triethylamine (3.6 mL, 26 mmol) in THF (50 mL).
Purified by column chromatography (Si2O, EtOAc) to afford a white
1
crystalline solid (2.69 g, 81%). Mp = 195−196 °C. H NMR (500
MHz, CDCl3) δ: 8.34 (s, 1H), 8.10 (d, J = 7.8 Hz, 1H), 7.96 (d, J = 6.4
Hz, 1H), 7.92 (d, J = 7.8 Hz, 2H), 7.79 (m, 1H), 7.61 (t, J = 7.3 Hz,
1H), 7.53 (t, J = 8.3 Hz, 2H), 2.24 (s, 3H). 13C{1H} NMR (125 MHz,
CDCl3) δ: 165.4, 149.5, 140.0, 134.2, 132.3, 128.9, 127.1, 109.6, 24.8.
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H14N3O2, 256.1086;
found 256.1097.
Syntheses. N,N′-(Pyridine-2,6-diyl)diacetamide (1a). A round-
bottom flask was charged with dry THF (50 mL), 2,6-diaminopyridine
(3.0 g, 28 mmol), and triethylamine (9.7 mL, 69 mmol). The flask was
then lowered into an ice bath and degassed with N2. Acetyl chloride
(4.3 mL, 61 mmol) was added to an addition funnel containing dry
THF (20 mL), and the resultant solution was then slowly added to the
diaminopyridine solution while stirring in the ice bath under N2. Once
the addition of the acid chloride was complete, the ice bath was
removed, and the reaction was allowed to warm to room temperature
overnight while stirring under N2. The reaction mixture was
concentrated by rotary evaporation, and the crude product was
purified by column chromatography (Si2O, EtOAc) to afford 1a as off-
white crystals (5.2 g, 96% yield) with spectroscopic properties
N-(6-Pivalamidopyridin-2-yl)benzamide (1f). The disubstituted
diaminopyridine 1f was prepared according to the general procedure
outlined for 1d with the following quantities: trimethylacetyl chloride
(0.24 mL, 2.1 mmol) in THF (25 mL) was added slowly to 2c (0.35 g,
1.6 mmol) and triethylamine (0.34 mL, 2.5 mmol) in THF (50 mL).
Purified by column chromatography (Si2O, CH2Cl2) to afford a chalky
off-white solid (0.51 g, 82%). Mp = 120−121 °C. 1H NMR (500 MHz,
CDCl3) δ: 8.33 (s, 1H), 8.06 (d, J = 8.3 Hz, 1H), 7.97 (d, J = 8.3 Hz,
1H), 7.94 (d, J = 4.3 Hz, 2H), 7.79 (s, 1H), 7.75 (t, J = 8.3, 1H), 7.56
(t, J = 7.3 Hz, 1H), 7.49 (t, J = 6.5 Hz, 2H), 1.32 (s, 9H). 13C{1H}
NMR (125 MHz, CDCl3) δ: 176.8, 165.4, 149.8, 149.6, 140.9, 134.2,
132.3, 128.9, 127.1, 109.7, 109.6, 39.8, 27.5. HRMS (ESI-TOF) m/z:
[M + H]+ Calcd for C17H20N3O2, 298.1556; found 298.1565.
N-(6-Aminopyridin-2-yl)acetamide (2a). A round-bottom flask was
charged with dry THF (10 mL) and 2,6-diaminopyridine (1.0 g, 9.1
mmol). The flask was then lowered into an ice bath and degassed with
N2. Acetyl chloride (0.32 mL, 4.6 mmol) was added to an addition
funnel containing dry THF (20 mL), and the resultant solution was
then added slowly to the diaminopyridine solution over the course of 1
h while stirring at 0 °C under N2. Once the addition of the acid
chloride was complete, the ice bath was removed and the reaction was
allowed to warm to room temperature overnight while stirring under
N2. The precipitate from the reaction was filtered, and the resultant
filtrate was concentrated by rotary evaporation. The crude product was
purified by column chromatography (SiO2, EtOAc) to afford a tannish
pink solid (0.65 g, 95%), with spectroscopic properties consistent with
literature data.32 Mp = 150−152 °C. 1H NMR (300 MHz, CDCl3) δ:
7.70 (s, 2H), 7.54−7.46 (m, 2H), 6.27 (d, J = 7.8 Hz, 1H), 4.32 (s,
2H), 2.18 (s, 3H). 13C{1H} NMR (125 MHz, CDCl3) δ: 168.4, 157.0,
149.7, 140.2, 104.3, 103.3, 24.7. HRMS (ESI-TOF) m/z: [M]+ Calcd
for C7H9N3O, 151.0746; found 151.0742.
consistent with literature data.32 Mp = 201−202 °C. H NMR (500
1
MHz, CDCl3) δ: 7.91 (d, J = 7.7 Hz, 2H), 7.73 (t, J = 7.9 Hz, 1H),
7.59 (s, 2H), 2.22 (s, 6H). 13C{1H} NMR (125 MHz, CDCl3) δ:
168.5, 149.4, 140.9, 109.5, 24.8. HRMS (ESI-TOF) m/z: [M + H]+
Calcd for C9H12N3O2, 194.0930; found 194.0932.
N,N′-(Pyridine-2,6-diyl)dipivalamide (1b). The monosubstituted
diaminopyridine 2b was prepared according to the general procedure
outlined for 1a with the following quantities: 2,6-diaminopyridine (33
mg, 0.30 mmol) in THF (15 mL) and trimethylacetyl chloride (81 μL,
0.66 mmol) in THF (15 mL). The crude product was purified by
column chromatography (Si2O, EtOAc) to afford a tan solid (83 mg,
99% yield) with spectroscopic properties consistent with literature
data.32 Mp = 112−113 °C. 1H NMR (500 MHz, CDCl3) δ: 7.94 (d, J
= 7.8 Hz, 2H), 7.76 (s, 2H), 7.71 (t, J = 7.8 Hz, 1H), 1.34 (s, 18H)
13C{1H} NMR (125 MHz, CDCl3) δ: 176.8, 149.6, 140.8, 109.3, 39.8,
27.5. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H24N3O2,
278.1869; found 278.1859.
N,N′-(Pyridine-2,6-diyl)dibenzamide (1c). The monosubstituted
diaminopyridine 1c was prepared according to the general procedure
outlined for 1a with the following quantities: 2,6-diaminopyridine (31
mg, 0.28 mmol) in THF (15 mL) and benzoyl chloride (72 μL, 0.62
mmol) in THF (15 mL). The crude product was purified by
chromatography (Si2O, 1:1 EtOAc/DCM) to afford a tan solid (89
mg, 98% yield) with spectroscopic properties consistent with literature
N-(6-Aminopyridin-2-yl)pivalamide (2b). The monosubstituted
diaminopyridine 2b was prepared according to the general procedure
outlined for 2a with the following quantities: 2,6-diaminopyridine
(0.51 g, 4.6 mmol) in THF (10 mL) and trimethylacetyl chloride (0.25
mL, 2.2 mmol) in THF (5 mL). Purified by column chromatography
(Si2O, EtOAc) to afford a tan solid (0.86 g, 97% yield), with
spectroscopic properties consistent with literature data.32 Mp = 131−
132 °C. 1H NMR (500 MHz, CDCl3) δ: 7.73 (s, 1H), 7.59 (d, J = 8.3
Hz, 1H), 7.46 (t, J = 7.8 Hz, 1H), 6.26 (d, J = 7.81 Hz, 1H), 4.35 (s,
2H), 1.32 (s, 9H). 13C{1H} NMR (125 MHz, CDCl3) δ: 168.3, 157.0,
149.8, 104.3, 103.3, 39.7, 27.5. HRMS (ESI-TOF) m/z: [M + H]+
Calcd for C10H16N3O, 194.1293; found 194.1295.
data.52 Mp = 168−170 °C. H NMR (500 MHz, CDCl3) δ: 8.53 (s,
1
2H), 8.14 (d, J = 7.8 Hz, 2H), 7.93 (d, J = 7.3 Hz, 4H), 7.84 (t, J = 7.7
Hz, 1H), 7.60 (t, J = 7.3 Hz, 2H), 7.53 (t, J = 7.3 Hz, 4H). 13C{1H}
NMR (125 MHz, CDCl3) δ: 170.0, 165.5, 149.7, 141.3, 134.1, 133.6,
132.37, 130.0, 128.9, 128.5, 127.2, 110.01. HRMS (ESI-TOF) m/z:
[M + H]+ Calcd for C19H16N3O2, 318.1243; found 318.1247.
N-(6-Acetamidopyridin-2-yl)pivalamide (1d). A round-bottom
flask was charged with dry THF (75 mL), 2a (2.9 g, 19 mmol), and
triethylamine (5.3 mL, 39 mmol). The flask was then lowered into an
ice bath and degassed with N2. Trimethylacetyl chloride (3.0 mL, 25
mmol) was added to an addition funnel containing dry THF (25 mL),
and the resultant acid chloride solution was then slowly added to the
diaminopyridine solution while stirring in the ice bath under N2. Once
the addition of the acid chloride was complete, the ice bath was
N-(6-Aminopyridin-2-yl)benzamide (2c). The monosubstituted
diaminopyridine 2c was prepared according to the general procedure
outlined for 2a with the following quantities: 2,6-diaminopyridine (2.0
g, 18 mmol) in THF (50 mL) and benzoyl chloride (1.0 mL, 9.0
G
dx.doi.org/10.1021/jo402500a | J. Org. Chem. XXXX, XXX, XXX−XXX